Elbit Imaging announces additional updates regarding 2 proposals on agenda of annual general meeting

NewsGuard 100/100 Score

Elbit Imaging Ltd. ("EI" or "Company") (NASDAQ GSM: EMITF) announced today further to the Company's announcement dated August 5, 2014, additional updates regarding two proposals on the agenda of its annual general meeting of shareholders scheduled to be held on August 14, 2014 (the "Meeting").

Proposal No. 4 - Compensation Policy for Officers and Directors 

With respect to the Company's proposed Compensation Policy for Directors and Officers, the Company has undertaken to Entropy Financial Research Ltd., an Israeli shareholder advisory firm, as follows:

Performance-based Bonus: Should a performance-based bonus be awarded to one of the Company's office holders, the Company will disclose in its subsequent annual report the degree to which such office holder satisfied each applicable performance target.

Proposal No. 6 - Consultancy Agreement with our Director, Mr. Boaz Lifschitz 

With respect to the Company's proposed Consultancy Agreement with our Director, Mr. Boaz Lifschitz, the Company has undertaken to Entropy Financial Research Ltd., an Israeli shareholder advisory firm, that such agreement be limited to a one-year term, and has clarified that the proposed arrangement is made due to the recent developments in the Company's business, the recent changes in the Company's management and in light of the Company's specific need for a bio-medical and medical technologies professional who is familiar with the Company's structure and business.

 

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Understanding long COVID: A call for better diagnosis and treatment